New Age Alpha Advisors LLC Takes $578,000 Position in ICU Medical, Inc. (NASDAQ:ICUI)

New Age Alpha Advisors LLC bought a new stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,728 shares of the medical instruments supplier's stock, valued at approximately $578,000.

Several other large investors have also modified their holdings of ICUI. Arizona State Retirement System boosted its stake in ICU Medical by 1.0% in the 4th quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier's stock worth $1,044,000 after purchasing an additional 65 shares during the period. Equitable Trust Co. boosted its position in shares of ICU Medical by 1.6% in the fourth quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier's stock worth $822,000 after buying an additional 84 shares during the period. LPL Financial LLC grew its holdings in shares of ICU Medical by 2.0% during the fourth quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier's stock valued at $747,000 after buying an additional 93 shares in the last quarter. Gagnon Securities LLC raised its position in ICU Medical by 0.5% during the fourth quarter. Gagnon Securities LLC now owns 28,881 shares of the medical instruments supplier's stock valued at $4,481,000 after buying an additional 137 shares during the period. Finally, Wealthspire Advisors LLC raised its position in ICU Medical by 6.4% during the fourth quarter. Wealthspire Advisors LLC now owns 2,660 shares of the medical instruments supplier's stock valued at $413,000 after buying an additional 160 shares during the period. 96.10% of the stock is owned by institutional investors.

Remove Ads

Analyst Upgrades and Downgrades

A number of research firms have issued reports on ICUI. Jefferies Financial Group upgraded shares of ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 target price for the company in a research note on Wednesday, December 11th. Raymond James set a $97.00 price objective on ICU Medical in a research report on Wednesday, March 12th. Finally, StockNews.com raised ICU Medical from a "hold" rating to a "buy" rating in a report on Friday. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Buy" and an average target price of $168.67.

ICU Medical Stock Down 1.6 %

Shares of ICUI stock traded down $2.25 on Friday, hitting $139.32. 597,700 shares of the stock were exchanged, compared to its average volume of 265,684. ICU Medical, Inc. has a fifty-two week low of $93.36 and a fifty-two week high of $196.26. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The business has a 50-day moving average of $151.64 and a 200 day moving average of $162.55. The firm has a market capitalization of $3.42 billion, a P/E ratio of -30.49 and a beta of 0.73.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.